Back
INmune Bio Vs. Celestica Industry Stock Comparison
Sell
32
INMB
INmune Bio
Last Price:
$7.65
Seasonality Move:
24.71%
Buy
52
CLS
Celestica
Last Price:
$60.60
Seasonality Move:
9.9%
Sell
32
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
-
The current INmune Bio [INMB] share price is $7.77. The Score for INMB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $7.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INMB is experiencing slight buying pressure.
CLS Stock Price Chart
INMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 47.77 | Sell |
Chaikin Money Flow: | 89262 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.6 - 8.34) | Sell |
Bollinger Bands (100): | (5.09 - 8.55) | Buy |
CLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.94 | Buy |
Relative Strength Index (14 RSI): | 31.37 | Sell |
Chaikin Money Flow: | -6876679 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.03 - 97.89) | Sell |
Bollinger Bands (100): | (82.61 - 115.11) | Sell |
INMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.85 | Sell |
20-day SMA: | 7.97 | Sell |
50-day SMA: | 8.4 | Sell |
200-day SMA: | 6.82 | Buy |
8-day EMA: | 7.84 | Sell |
20-day EMA: | 7.96 | Sell |
50-day EMA: | 7.82 | Sell |
200-day EMA: | 7.42 | Buy |
CLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.69 | Sell |
20-day SMA: | 87.38 | Sell |
50-day SMA: | 105.52 | Sell |
200-day SMA: | 76.67 | Sell |
8-day EMA: | 75.5 | Sell |
20-day EMA: | 56.08 | Buy |
50-day EMA: | 30.47 | Buy |
200-day EMA: | 9 | Buy |
INmune Bio Earnings Growth & INMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.16 per share, an increase this year of $0.44 per share, and an increase next year of $0.09 per share.
Celestica Earnings Growth & CLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.10 per share, an increase this year of $0.96 per share, and an increase next year of $1.06 per share.
INmune Bio Technical Analysis
Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Celestica Technical Analysis
Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |